ArticleJGH open : an open access journal of gastroenterology and hepatology2026
Assessing Lymph Node Metastasis Risk in Patients With Mucosal Gastric Cancer: A Comparison of the WHO and Japanese Criteria and Implications for Endoscopic Submucosal Dissection.
Article in JGH open : an open access journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Endoscopic submucosal dissection (ESD) is an established treatment for early gastric cancer. However, concerns remain regarding the risk of lymph node metastasis (LNM) under expanded criteria and its applicability across different populations. This study assessed LNM risk in patients with mucosal gastric cancer using WHO and Japanese criteria. Methods: This retrospective cohort study included 2232 patients with mucosal gastric cancer who underwent curative gastrectomy. Clinicopathological factors, including tumor size, histological type, ulceration, and lymphovascular invasion (LVI), were analyzed. Independent risk factors for LNM were identified through multivariate logistic regression. Results: LNM occurred in 3.5% of the patients. Undifferentiated-type (UD-type) tumors within the updated ESD criteria (size ≤ 2 cm, without ulceration) had a 2.1% LNM occurrence rate. In contrast, differentiated-type (D-type) tumors (no ulceration with size > 2 cm or presence of ulceration with size ≤ 3 cm) showed 3.3% and 1.4% LNM occurrence rates, respectively. The pattern of lymph node metastasis at each station indicated that D1+ lymph node dissection is sufficient for mucosal gastric cancers. Multivariate analysis identified large tumor size, ulceration, UD-type, and LVI as significant LNM risk factors, with UD-type tumors consistently showing higher LNM rates than D-type tumors across different size categories. Conclusions: These findings underscore the LNM risk in mucosal gastric cancer under the updated ESD criteria. Individualized treatment and counseling, particularly for young patients with good performance status, are essential. A cautious approach aligning treatment with patient characteristics is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.